feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    b3kat_BV001126916
    Format: 430 S.
    ISBN: 3465017331
    Series Statement: Studien zur europäischen Rechtsgeschichte 28
    Language: Italian
    Subjects: Law , General works
    RVK:
    RVK:
    Keywords: Università degli studi di Padova ; Jurist ; Geschichte 1400-1509 ; Universität Padua Facoltà di Giurisprudenza ; Hochschullehrer ; Geschichte 1400-1500 ; Jurist ; Università degli studi di Padova ; Geschichte 1400-1500 ; Università degli studi di Padova ; Rechtslehrer ; Geschichte 1400-1500 ; Università degli studi di Padova ; Rechtslehrer ; Geschichte 1400-1509 ; Universität Padua Facoltà di Giurisprudenza ; Geschichte 1400-1500 ; Università degli studi di Padova ; Geschichte 1400-1500 ; Hochschullehrer ; Rechtswissenschaft ; Università degli studi di Padova ; Rechtswissenschaft ; Hochschullehrer ; Geschichte 1400-1509 ; Bibliografie ; Biografie ; Verzeichnis ; Verzeichnis ; Bibliografie ; Biografie
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    b3kat_BV002460206
    Format: X, 452 S.
    ISBN: 3465022017
    Series Statement: Studien zur europäischen Rechtsgeschichte 43
    Language: Italian
    Subjects: Law , Theology
    RVK:
    RVK:
    RVK:
    RVK:
    Keywords: Bürgerliches Recht ; Geschichte 1200-1300 ; Quelle ; Quelle
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    UID:
    gbv_876211449
    Format: 1 Online-Ressource (circa 76 Seiten) , Illustrationen
    Series Statement: OECD health working papers no. 87
    Content: Across OECD countries, pharmaceutical spending reached around USD 800 billion in 2013, accounting for about 20% of total health spending on average when pharmaceutical consumption in hospital is added to the purchase of pharmaceutical drugs in the retail sector. This paper looks at recent trends in pharmaceutical spending across OECD countries. It examines the drivers of recent spending trends, highlighting differences across therapeutic classes. While the consumption of medicines continues to increase and to push pharmaceutical spending up, cost-containment policies and patent expiries of a number of top-selling products have exerted downward pressure on pharmaceutical expenditures in recent years. This resulted in a slower pace of growth over the past decade. The paper then looks at emerging challenges for policy makers in the management of pharmaceutical spending. The proliferation of high-cost specialty medicines will be a major driver of health spending growth in the coming years. While some of these medicines bring great benefits to patients, others provide only marginal improvements. This challenges the efficiency of pharmaceutical spending.
    Note: Zusammenfassung in französischer Sprache
    Language: English
    Keywords: Arbeitspapier ; Graue Literatur
    Author information: Paris, Valérie
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Paris : OECD Publishing
    UID:
    b3kat_BV047932195
    Format: 1 Online-Ressource (73 Seiten) , 21 x 29.7cm
    Series Statement: OECD Health Working Papers
    Content: This study analyses how 14 OECD Countries refer to "value" when making decisions on reimbursement and prices of new medicines. It details the type of outcomes considered, the perspective and methods adopted for economic evaluation when used; and the consideration of budget impact. It describes which dimensions are taken into account in the assessment of "innovativeness" and the consequences of this assessment on prices; it confirms that treatments for severe and/or rare diseases are often more valued than others and shows how countries use product-specific agreements in an attempt to better align value and price
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    b3kat_BV047933658
    Format: 1 Online-Ressource (50 Seiten) , 21 x 29.7cm
    Series Statement: OECD Health Working Papers
    Content: Taxes and other fiscal measures on health-related commodities are in widespread use. Alcoholic beverages and tobacco products have been subjected to taxation for a long time in most countries. Several OECD governments have passed legislation to increase existing taxes or to introduce new taxes on foods high in salt, sugar or fat in the past few years. Traditionally, commodity taxes have been primarily seen as a source of fiscal revenues and a way to address consumption externalities. More recently, an increased emphasis has been placed on the potential health benefits of commodity taxation, as evidence emerged of the adverse public health, social and economic consequences of the consumption of a range of commodities. This paper provides a review of the theoretical arguments and empirical evidence on the key factors that governments must address when considering the adoption of fiscal measures for health promotion, highlighting the strengths, as well as the limitations and pitfalls, of specific measures. The main focus of this paper is on taxes on health-related commodities, although a range of other fiscal measures may potentially be used in health promotion. Existing evidence of effects on consumption and health outcomes points to the conclusion that taxes on healthrelated commodities can be a powerful tool for health promotion, although the variety and complexity of the effects they generate require careful consideration by policy makers who intend to adopt new taxes or reform existing ones. The arguments in support of taxes being used to attain public health objectives are strong for tobacco products and alcoholic beverages, but less clear-cut for foods, in which case the value of using taxes is highly dependent on their design and on the context in which they would be applied
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    UID:
    gbv_788926861
    Format: Online-Ressource (50 S.) , graph. Darst.
    Series Statement: OECD health working papers 66
    Content: Taxes and other fiscal measures on health-related commodities are in widespread use. Alcoholic beverages and tobacco products have been subjected to taxation for a long time in most countries. Several OECD governments have passed legislation to increase existing taxes or to introduce new taxes on foods high in salt, sugar or fat in the past few years. Traditionally, commodity taxes have been primarily seen as a source of fiscal revenues and a way to address consumption externalities. More recently, an increased emphasis has been placed on the potential health benefits of commodity taxation, as evidence emerged of the adverse public health, social and economic consequences of the consumption of a range of commodities. This paper provides a review of the theoretical arguments and empirical evidence on the key factors that governments must address when considering the adoption of fiscal measures for health promotion, highlighting the strengths, as well as the limitations and pitfalls, of specific measures. The main focus of this paper is on taxes on health-related commodities, although a range of other fiscal measures may potentially be used in health promotion. Existing evidence of effects on consumption and health outcomes points to the conclusion that taxes on healthrelated commodities can be a powerful tool for health promotion, although the variety and complexity of the effects they generate require careful consideration by policy makers who intend to adopt new taxes or reform existing ones. The arguments in support of taxes being used to attain public health objectives are strong for tobacco products and alcoholic beverages, but less clear-cut for foods, in which case the value of using taxes is highly dependent on their design and on the context in which they would be applied.
    Note: Zsfassung in franz. Sprache , Systemvoraussetzungen: Acrobat Reader.
    Language: English
    Keywords: Arbeitspapier ; Graue Literatur
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    UID:
    b3kat_BV047930978
    Format: 1 Online-Ressource (75 Seiten) , 21 x 29.7cm
    Series Statement: OECD Health Working Papers
    Content: Across OECD countries, pharmaceutical spending reached around USD 800 billion in 2013, accounting for about 20% of total health spending on average when pharmaceutical consumption in hospital is added to the purchase of pharmaceutical drugs in the retail sector. This paper looks at recent trends in pharmaceutical spending across OECD countries. It examines the drivers of recent spending trends, highlighting differences across therapeutic classes. While the consumption of medicines continues to increase and to push pharmaceutical spending up, cost-containment policies and patent expiries of a number of top-selling products have exerted downward pressure on pharmaceutical expenditures in recent years. This resulted in a slower pace of growth over the past decade. The paper then looks at emerging challenges for policy makers in the management of pharmaceutical spending. The proliferation of high-cost specialty medicines will be a major driver of health spending growth in the coming years. While some of these medicines bring great benefits to patients, others provide only marginal improvements. This challenges the efficiency of pharmaceutical spending
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Paris : OECD
    UID:
    gbv_755399048
    Format: Online-Ressource (73 S.) , graph. Darst.
    Series Statement: OECD health working papers 63
    Content: This study analyses how 14 OECD Countries refer to “value” when making decisions on reimbursement and prices of new medicines. It details the type of outcomes considered, the perspective and methods adopted for economic evaluation when used; and the consideration of budget impact. It describes which dimensions are taken into account in the assessment of “innovativeness” and the consequences of this assessment on prices; it confirms that treatments for severe and/or rare diseases are often more valued than others and shows how countries use product-specific agreements in an attempt to better align value and price.
    Note: Zsfassung in franz. Sprache , Systemvoraussetzungen: Acrobat Reader.
    Language: English
    Keywords: Arbeitspapier ; Graue Literatur
    Author information: Paris, Valérie
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    UID:
    b3kat_BV003453014
    Format: XCV, 255 S.
    Series Statement: Medioeva e umanesimo 21
    Language: Italian
    Subjects: General works
    RVK:
    Keywords: Biblioteca Capitolare ; Handschrift ; Katalog
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Book
    Book
    Padova : Editrice Antenore
    UID:
    gbv_1074470486
    Format: XCV, 255 S , Ill
    Series Statement: Medioevo e umanesimo 21
    Language: Italian
    Subjects: General works
    RVK:
    Keywords: Biblioteca Capitolare ; Handschrift ; Katalog
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages